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During the last two decades an increasing number of different diseases with permanent insufficiency of immune mechanisms have been identified and usually classified, as recommended by a W H O committee, on the basis of the T -and B-cell concept (7) . An entirely new possibility, i.e., a biochemical approach, was raised by the detection of adenosine deaminase (ADA) deficiency (5) in the erythrocyte$, lymphocytes, and serum of patients with combined immunodeficiency (SCID). The lack of this enzyme is transmitted as an autosomal recessive trait from heterozygous "healthy" parents to a homozygous and mortally sick child. Because the ADA assay is sensitive enough to detect heterozygous carries (27) . it was possible to reinvestigate the families of a number of our patients who had died of S C I D (12, 13, 28) . Among nine families, three parent couples had significantly reduced ADA activity. Two of these had each one living infant with SCID, who indeed had practically absent ADA activity.
solution, pH 7.5, and sonicated (Braun Sonic 300; 270 W) for 5 sec. T o 3 ml hemolysate 5 p1 xanthinoxydase (Bohringer) were added and allowed to equilibrate for 15 min at 37'. The reaction was initiated by adding 75 pl adenosine solution (I mg/ml); immediately the increase in extinction due to formation of uric acid was measured at 293 nm for 10 min at 37'. The enzyme activity is expressed as pmol adenosine deaminated/min/mmol Hb/liter.
ADA ACTIVITY IN S E R U M (6, 18)
Goldberg's method was slightly modified, the decrease of extinction being measured at 265 nm for 30 min at 37'. One hundred microliters of serum + 3 ml phosphate buffer, 0.05 M , pH 7.5, were equilibrated for 15 min at 37'. Then 75 p1 adenosine solution (1 mg/ml) were added, and the extinction was measured for 30 min. Calculation is based on the molar extinction coefficient of 9.1 cm2/pmol, and the enzyme activity is expressed as micromoles of adenosine deaminated per min per liter of serum ( 18) . (18) ~~m~h o c~i e s are separated over a Ficoll-Hypaque gradient (26) . washed three times with normal saline, and counted; a suspension containing 130,000 cells/ml was prepared with phosphate buffer 0.05 M , pH 7.5, and sonicated with 240 W for 30 sec. Three milliliters of the sonicated debris were again equilibrated at 37". The enzyme reaction was started by adding 75 adenosine solution, and the decrease of the extinction at 265 nm was measured for 30 min at 37'. Enzyme activity was calculated, using the molar extinction coefficient of 8.1 cm2pmol, and activity is given as micromoles of adenosine deaminated per min per lo6 lymphocytes. (Figs. 3 and 4) , i.e., 54 people, including 2 children with SCID.
ADA ACTIVITY IN S O N I C A T E D L Y M P H O C Y T E S

METHODS RESULTS
ADA activity was measured in hemolyzed erythrocytes (dupliNormal ADA values with 2 S D (30 males, 30 females) and care), in serum and in lymphocytes (single measurements) by a standard error of the mean as calculated from multiple measurespectrophotometric method (6, 15, 18 ) using a Zeiss PM Q 11 ments of the same specimen are given in Table 1 . Values for the spectrophotometer with thermostatized quartz cuvettes (I cm same person determined on different days remained very stable. depth) and automatic recording.
ADA activities of all family members are charted in Figure 4 .
Fifty microliters of sedimented erythrocytes (three times washed This family living in a remote mountain valley of southeastern with saline) were suspended in 15 ml 0.05 M phosphate buffer Switzerland, has lost three boys to S C I D at ages 6, 9, and 15 months; these cases have been published (14) . The surviving two siblings are healthy. Multiple consanguinity of their parents was detected by interviewing family members and certified by inquiries in the official church books and civil state registers. One of the surviving siblings, both parents, three siblings of the parents, the maternal grandmother, and one brother of the paternal grandfather were identified as heterozygous carriers. The probable gene track is outlined by heavy lines in the pedigree (Fig. 1) .
F A M I L Y K
This family from a secluded pre-alpine valley of Central Switzerland, shows similar multiple consanguinity (Fig. 2) . The second child ( I X 3) died of S C l D in 1973, but before his death complete deficiency of ADA could be ascertained (32) .
The father (VIII 3) and one of his brothers (VIII 4) have significantly diminished ADA activity, but the mother's (VIII 6) and two of her sisters' (VIII 7 and VIII 9) ADA activity is well within the normal range. The paternal grandfather (VII 3) is heterozygous, and so is one of his brothers (VII 4). In contrast to the normal result in the mother, the situation in her parents seems clear, her father (VII 7) being normal, but her mother (711 10) presenting diminished ADA activity. Multiple consanguinity of the parents is evident from the pedigree, once in the 5th degree, once in the 7th degree, three times in the I l th, and once in the 12th degree.
FA M I L Y SCH
Family Sch (Figs. 3 and 4) , was discovered at the beginning of this study. The young parents are not consanguineous. Their only children were binovular twin girls (Fig. 3) . One of these was admitted at the age of 5 months to our hospital and died within 4 days of severe lung infection. Autopsy revealed a rudimentary thymus and all the other typical findings of SCID. When her sister was admitted for evaluation she already suffered from severe lung infection. ADA deficiency was found in three successive blood specimens. Her lung condition necessitated artificial respiration for 6 days, but after implantation of one fetal liver (16 x 10' cells given intravenously, fetal gestational age 12 weeks) and thymus the child recovered and all her immunologic functions and ADA activity of her lymphocytes (but not of her erythrocytes) became slowly normal. At the present time, 18 months after this transplant, the child is healthy and well developed in every respect, and her immune functions are normal.
The mother is clearly heterozygous, and so is one of her brothers and her father. The father of the patient, however, has only slightly reduced ADA activity, but since his mother ( I 2) is unequivocally a heterozygote, he is with high probability a gene carrier.
DISCUSSION
The activity of the enzyme adenosine deaminase (ADA) seems to be individually rather constant and age-independent. We could confirm that the dav-to-dav.variation in the same oerson is not significant. Changes due to disease, pregnancy, or drugs are not known. Therefore the severe diminution of ADA activity in patients with S C I D (3, 5 , 19, 20, 24, 25, 29, 31 ) is most remarkable, and until now only one apparently healthy individual with lack of erythrocyte ADA has been detected (17) . According to Scott et a/. (27) . the heterozygous carriers of the deficient gene can be recognized in most cases, and this seems very important for genetic counseling. However, the mother in farni!v K (Fig. 2, VIII  6 ) presents an exception to this rule, which is explained by different penetrance of the gene, since her mother (Fig. 2, VII 10) has unequivocally diminished levels.
Comparison of clinical and laboratory findings of patients with and without ADA deficiency reveals some differences: most patients with lack of the enzyme have a tendency to very marked lymphocytopenia, but less pronounced decrease of the immunoglobulins. This striking dissociation prompted us in 1971 to publish farni1.v B as special form of "norrnogammaglobulinemic antibody deficiency syndrome with severe impairment of the cellular immune reactions" (14) . We suspected that the Ntzelof syndrome (19, 20) came to similar conclusions.
Histologic findings raise the possibility of secondary involution or destruction of a primarily normal lymphatic system (14) ; although all autopsied children had a hypoplastic thymus, we found one weighing 4.1 g, which is unusually high for SCID. The 'thymic involution in the three sons of family B was more pronounced the longer the patient survived; in two boys who died early (at 6 and 9 months of age) some Hassal's bodies could be found, while in the third boy, who survived to 15 months, no such structures could be seen. The peripheral lymphatic system presented a severe depletion of lymphocytes and complete absence of germinal centers. In contrast, however, plasma cells were unequivocally present. This is in keeping with the essentially normal immunoglobulin levels, but specific antibody functions were absent. The parallel of the morphologic dissociation between plasma cells and disturbed lymph node architecture and functional discrepancy between immunoglobulin levels and deficiency of antibodies is striking. It is another hint for a regressive change within the lymphoid system during the course of the disease leading to increasing sclerosis.
Little is known as yet concerning the connection between ADA and the immune system or immune function. Meuwissen and Pollara (20, 24, 25) have reviewed the presently available evidence.
1. After local antigenic stimulation the efferent lymphatics contain increased activity of ADA and higher immunoglobulin concentrations.
2. Adenosine and its metabolites, especially the monophosphate, are toxic for cell cultures in high concentrations ( > 2 x M), and mainly for lymphoid cells (16) . They might therefore be deleterious to rapidly proliferating lymphoid organs. Equally, inosine, which results from the deamination of adenosine by ADA, seems to play an important role in the metabolism of lymphocytes, especially of the T-cells (2, 8, 9, 22, 30) .
3. Molecular heterogeneity of ADA is well known (4). Erythrocytes contain the small molecular form exclusively, but in most tissues polymers are found (4, 10, 29). These two forms can be transformed into each other by a tissue factor isolated from lung (1). For the time being, the determination of ADA activities is of considerable practical diagnostic value for the detection of SCID, since both the heterozygous gene carriers and the homozygous patients can be identified. assay is sensitive enough to distinguish normal subjects, heterozygous gene carriers, and homozygous patients. A retrospective study of Families known for patients who had died of S C I D revealed ADA deficiency in three out of nine. Extensive pedigrees of these three families show the distribution of the deficient gene: 6 S C I D patients, presumaly homozygotes for ADA deficiency (proven in 2), 6 heterozygote parents, 14 other heterozygote relatives, and 32 homozygote normal subjects. The possible connections between metabolic pathways of adenosine and pathogenesis of S C I D are discussed. 
